In the face of brutal management, battered vaccine maker still finds reason for hope

Daniel is responsible for the interface between the healthcare industry and the federal government. He reports on corporate influence in government, the health impacts of federal policy, and health care policy. Sensitive information can be sent via Signal (danielp.100).

SAN DIEGO — These are unusual times for the vaccine business. But in the view of those gathered at the BIO International Conference this week, the picture is anything but bleak.

In fact, some vaccine makers feel more optimistic than they were a year ago, at least given the circumstances.

In an interview with STAT, they acknowledged that Secretary of Health and Human Services Robert F. Kennedy Jr., a longtime vaccine critic, had wrought previously unthinkable disruptions, including canceling major mRNA vaccine contracts, eliminating universal vaccine recommendations, and cutting government funding for research, and that Washington could do more in the future.

STAT+ exclusive story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Subscribe to STAT+ for this article and daily analysis of market-moving biopharmaceuticals.

Already have an account? Log in

Individual plan Group plan See all plans

To read the rest of this story, subscribe to STAT+.

Subscribe



Source link